Pazopanib Spirig HC 200 mg Filmtabletten

Country: Շվեյցարիա

language: գերմաներեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

pazopanibum

MAH:

Spirig HealthCare AG

ATC_code:

L01EX03

INN:

pazopanibum

pharmaceutical_form:

Filmtabletten

composition:

pazopanibum 200 mg ut pazopanibi hydrochloridum, cellulosum microcristallinum, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), polysorbatum 80, pro compresso obducto corresp. natrium max. 1.10 mg.

class:

A

therapeutic_group:

Synthetika

therapeutic_area:

Behandlung des Nierenzellkarzinoms ; Behandlung des fortgeschrittenen Weichteilsarkoms

authorization_status:

zugelassen

authorization_date:

2023-10-06